|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:CDC37-ELL (FusionGDB2 ID:14818) |
Fusion Gene Summary for CDC37-ELL |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CDC37-ELL | Fusion gene ID: 14818 | Hgene | Tgene | Gene symbol | CDC37 | ELL | Gene ID | 11140 | 8178 |
| Gene name | cell division cycle 37, HSP90 cochaperone | elongation factor for RNA polymerase II | |
| Synonyms | P50CDC37 | C19orf17|ELL1|MEN|PPP1R68 | |
| Cytomap | 19p13.2 | 19p13.11 | |
| Type of gene | protein-coding | protein-coding | |
| Description | hsp90 co-chaperone Cdc37CDC37 (cell division cycle 37, S. cerevisiae, homolog)CDC37 cell division cycle 37 homologcell division cycle 37 homologhsp90 chaperone protein kinase-targeting subunit | RNA polymerase II elongation factor ELLELL gene (11-19 lysine-rich leukemia gene)ELL/KMT2A fusionELL/KMT2A fusion proteinKMT2A/ELL fusionKMT2A/ELL fusion proteineleven-nineteen lysine-rich leukemia proteinelongation factor RNA polymerase IIprotein | |
| Modification date | 20200327 | 20200319 | |
| UniProtAcc | Q16543 | O00472 | |
| Ensembl transtripts involved in fusion gene | ENST00000222005, | ENST00000596124, ENST00000262809, | |
| Fusion gene scores | * DoF score | 6 X 6 X 5=180 | 11 X 17 X 7=1309 |
| # samples | 9 | 21 | |
| ** MAII score | log2(9/180*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(21/1309*10)=-2.64000386427912 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: CDC37 [Title/Abstract] AND ELL [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | CDC37(10514054)-ELL(18583692), # samples:3 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | ELL | GO:0010923 | negative regulation of phosphatase activity | 19389623 |
| Fusion gene breakpoints across CDC37 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across ELL (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | LUAD | TCGA-05-4426-01A | CDC37 | chr19 | 10514054 | - | ELL | chr19 | 18583692 | - |
Top |
Fusion Gene ORF analysis for CDC37-ELL |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-5UTR | ENST00000222005 | ENST00000596124 | CDC37 | chr19 | 10514054 | - | ELL | chr19 | 18583692 | - |
| In-frame | ENST00000222005 | ENST00000262809 | CDC37 | chr19 | 10514054 | - | ELL | chr19 | 18583692 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000222005 | CDC37 | chr19 | 10514054 | - | ENST00000262809 | ELL | chr19 | 18583692 | - | 3976 | 156 | 36 | 1886 | 616 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000222005 | ENST00000262809 | CDC37 | chr19 | 10514054 | - | ELL | chr19 | 18583692 | - | 0.020558305 | 0.97944176 |
Top |
Fusion Genomic Features for CDC37-ELL |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for CDC37-ELL |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr19:10514054/chr19:18583692) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| CDC37 | ELL |
| FUNCTION: Co-chaperone that binds to numerous kinases and promotes their interaction with the Hsp90 complex, resulting in stabilization and promotion of their activity (PubMed:8666233). Inhibits HSP90AA1 ATPase activity (PubMed:23569206). {ECO:0000269|PubMed:23569206, ECO:0000269|PubMed:8666233}. | FUNCTION: Elongation factor component of the super elongation complex (SEC), a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. Component of the little elongation complex (LEC), a complex required to regulate small nuclear RNA (snRNA) gene transcription by RNA polymerase II and III (PubMed:22195968). Plays a role in immunoglobulin secretion in plasma cells: directs efficient alternative mRNA processing, influencing both proximal poly(A) site choice and exon skipping, as well as immunoglobulin heavy chain (IgH) alternative processing. Probably acts by regulating histone modifications accompanying transition from membrane-specific to secretory IgH mRNA expression. {ECO:0000269|PubMed:20159561, ECO:0000269|PubMed:20471948, ECO:0000269|PubMed:22195968, ECO:0000269|PubMed:23251033}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | ELL | chr19:10514054 | chr19:18583692 | ENST00000262809 | 0 | 12 | 445_459 | 45 | 622.0 | Motif | Nuclear localization signal |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for CDC37-ELL |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >14818_14818_1_CDC37-ELL_CDC37_chr19_10514054_ENST00000222005_ELL_chr19_18583692_ENST00000262809_length(transcript)=3976nt_BP=156nt TGCTGCCGCCGTCGCCGCCACCCGAGCCGGAGCGGGCTGGGCCGCCAAGGCAAGATGGTGGACTACAGCGTGTGGGACCACATTGAGGTG TCTGATGATGAAGACGAGACGCACCCCAACATCGACACGGCCAGTCTCTTCCGCTGGCGGCATCAGGATTCTGTTTCACTGAGGCCATCT ATCCGATTTCAAGGAAGCCAAGGGCACATCTCCATCCCCCAGCCTGACTGCCCCGCAGAGGCGCGGACGTTCTCCTTCTACCTCTCCAAC ATCGGCCGCGACAACCCCCAGGGCAGCTTCGACTGCATCCAGCAGTATGTCTCCAGTCATGGGGAAGTTCACCTGGACTGCCTGGGCAGC ATACAGGACAAGATCACGGTGTGTGCCACCGACGACTCCTACCAGAAGGCGCGGCAGAGCATGGCCCAGGCGGAGGAGGAGACGCGGAGC CGAAGTGCCATTGTCATCAAGGCTGGAGGCCGCTACCTGGGCAAGAAGGTTCAGTTTCGGAAACCAGCCCCAGGTGCAACAGACGCGGTG CCCTCCCGGAAGCGGGCAACCCCCATCAACTTGGCGAGTGCCATCAGGAAGAGTGGTGCCAGTGCCGTGAGTGGGGGCAGCGGGGTGTCC CAGAGGCCCTTCCGTGACCGAGTGCTGCACCTCCTGGCACTACGGCCCTACCGCAAGGCTGAGCTGCTGCTGCGACTGCAGAAGGACGGC CTGACGCAGGCGGACAAGGACGCGCTGGATGGCCTCCTCCAGCAGGTGGCCAACATGAGTGCTAAGGACGGCACGTGTACACTGCAGGAC TGCATGTACAAGGATGTGCAGAAGGACTGGCCTGGCTACTCGGAGGGGGACCAGCAGCTGCTGAAGCGGGTGCTCGTCCGGAAGCTGTGC CAGCCACAGAGCACTGGCAGCCTCCTTGGAGACCCTGCTGCCTCCAGCCCCCCAGGCGAGCGTGGGCGCTCGGCCTCGCCCCCACAGAAG CGGCTGCAGCCTCCTGATTTCATCGACCCCCTAGCCAACAAGAAACCCCGGATATCGCACTTCACTCAGAGAGCTCAGCCTGCCGTCAAC GGGAAGCTGGGCGTGCCCAATGGCCGTGAGGCCTTGCTGCCCACCCCGGGCCCACCAGCCAGCACGGACACCCTCAGCTCCAGCACTCAC CTGCCCCCGCGGCTGGAGCCCCCGAGGGCCCACGACCCCCTGGCCGATGTCAGCAATGACCTGGGCCACAGCGGCCGAGACTGTGAGCAC GGAGAGGCGGCTGCCCCAGCCCCCACTGTGCGCCTCGGCCTGCCCCTGCTGACGGACTGTGCCCAGCCCAGCAGGCCACACGGCAGCCCC TCGCGCAGCAAGCCCAAGAAGAAGTCCAAGAAGCACAAAGACAAGGAGAGGGCGGCTGAGGACAAGCCCCGGGCCCAGCTTCCAGACTGT GCACCTGCCACCCATGCCACCCCCGGAGCCCCAGCAGACACCCCAGGTTTAAACGGAACCTGCAGCGTTTCCAGTGTTCCCACGTCCACG TCGGAGACGCCTGACTACTTGCTGAAGTACGCAGCCATCTCCTCTTCGGAGCAGCGCCAGAGCTACAAGAACGACTTCAATGCCGAGTAC AGCGAGTACCGCGACCTGCACGCCCGCATTGAGCGCATCACGCGGCGGTTCACCCAGCTCGACGCCCAGCTCCGGCAGCTCTCCCAGGGC TCCGAGGAGTATGAGACTACTCGAGGGCAGATTTTGCAGGAATATCGAAAAATCAAAAAGACCAACACCAACTACAGCCAGGAGAAGCAC CGCTGCGAGTACCTGCACAGCAAGCTGGCCCACATCAAGAGGCTCATCGCCGAGTACGACCAGCGGCAGCTGCAGGCTTGGCCCTAGCCG CCCTCCCCGATGGCGGGGATCTGGGAGGGTCGGGGGAGCAAAAGGCGGTGAGAGAGGATTTATTTAAAAAAATAAACCCGAGGAAGATGC TCATCTGAGCCAGCACCGCCGGCTTTCAGGGCAGCCCCTGCAGACGTCTGGCCCTGGCGGGTGGCTGCAAGCCCACCTCGGCCCTCCCTG CGCTTCCTGAGCAGTCCCTGCTTATGATGGGCTCCCCAGGAAGCCCACTGCCTCCTCCCTGGCTGCAGCCTCCGGGGTTCAGCCTCCTGT CTCGCCAGAAGACTCCTAGGCCCTTGGGGTGGCGCGCCTGCCTTTTCTAGTTTTATACAAAGACAGCCACTTTTAGCTACTGCTAATGAG ACTTGAGTCTATTTTTGTACAAAAGAGAAGCAAAATCTTTTTTCTAAACCTGTGCCTCCCTCTCCTCGGACACCCAGGGTCTAGCCGCTG CCCTGGGTCCTGCCTGCAGTATTACAGAGGTCGTCGAAAGGTGCAGCTGCGTTCTGAGGGCGTGGGGAATGGGCAGGTGGCCTCTGCTGG TCTCTGGCTCTACGTTTAGGCACCCCTTTCCCCAGCCTCTCCTCCTTGGGCAGGGTCTCTGCTCCAGCAAGCAAACAGGGTGGCCCAGGT GGCTATTTTGAGAACTCCAGCTGGTGCCCCCAGACAGCTGCTCAGAGCCAAGGGGGCAGAGGGCTTTCAGCGCCCCCAGGCCTGCCCTGC TATTTCAGGCCCTCAGCTGTCGGGGGCCACTGTGTTTCTGTGCTCCAAGTTGAGACTCGGCCGCAGCGGCGTCAGACTTTTCTTTGCGAT GTCCTCGGTTTCCCATTTGTTGCTGCTGCTGCTCATTCCACACTGTTGAGACCTTGTGGTCTCGATGCTGCTGGCCTCCCTCCGTCCCTC TGTCCACTTGTGGGTCCTGGGGTCGTCTTAGCAGAGCCACCGCCAAGGTTTGCACTCAGGGAGGGGCTGATGGAGGGCTGGGCGCCATGG GGTCAGGGAGGCCCCAGGGACCCATGGGCAGAGCTGGGGAGCCAGGAGGATGGGTCTGCCTGCTCTGGGGGTGCAGGCTCTGCAGACACC CCAATTGCTGCTCTGTTGCTGTGCCTAGTCTAGTGTCCCCCAAAGCATCGGGGGGCCACGCAAGTGTGGGTGTGTGAGTGTGCGTATGTG GGGACCCCCCAGGGCATGGTGGGGTCTGAGGCGTGTGTTCCCATTTAGGGCTGAATGAAGCCATGACTTGGAAAGGTGGTGGGGGGTGGA TGGCGGCTGTGACTCAGGGCCCAGGGATCACATGGGGGTCACTGCTGCCATCAGCAGTCAGGCAGGGAGAACAGAAATGCAAAAATACAG ATGTCTATTTTTCTAAACTGGGGGGTGGAGGGGTGCCTCCTGACAGCTTCCAAAGAGCTGACTGTGGAGGGCCCACAGTGTATCCCACCC CTGCCCGAGAGTCTCTCTCCTTTGGGACCCCCGGGTTCCCAGAGCTCCGAGGAAACTGATCCTTCATGTTTCAATAGCTGTTGTTGTTTT TCTCTTTGGGCCGGGCCGGGCCGGGGAAGGGCCGAGCAGGCTCCAGGAGGCCTCCAGAGTCAGCTGGACCTTGCTGTGTCGCCCGCAGGC AGCCCTGCAGACACCGGTGAGGTGGGATGATTTCAGGAGGTCCCAGCCCGGGACTGCCCGCCCCTCTGCCCTGGGAACCAGTCCAAGGGG CTGTCAGTTGAATTTGCCTTTTTGTTGTTGTTGTTGTTTTTGTTGTTTATTTGTTCTCCTTTTAAGGAATTATGAAGCTAAGAAAAGTTT TGTGTTTTGGGGGTTGGTGGACAAAGTTCTAGCTGATTAAATATGGTCTAACTTATTGATACTATTTTTTTTTCTTTTAATGTTGTACTG TGGAGAAAAACTATTTTGAGCCATGGGGTTGGTGTTTACAAGAACTTTCCACTTTTGCCAAAATGTTACAATTGAAAGGCATCTATCTGC GTCTTCAGTTTCCTGATATTTTCTTAAAAGATCTAGTGTCCTTTTTGTACACTAAACAGGTGAATGCTGACTTTTTTCATTCTCCAATAA >14818_14818_1_CDC37-ELL_CDC37_chr19_10514054_ENST00000222005_ELL_chr19_18583692_ENST00000262809_length(amino acids)=616AA_BP=40 MGRQGKMVDYSVWDHIEVSDDEDETHPNIDTASLFRWRHQDSVSLRPSIRFQGSQGHISIPQPDCPAEARTFSFYLSNIGRDNPQGSFDC IQQYVSSHGEVHLDCLGSIQDKITVCATDDSYQKARQSMAQAEEETRSRSAIVIKAGGRYLGKKVQFRKPAPGATDAVPSRKRATPINLA SAIRKSGASAVSGGSGVSQRPFRDRVLHLLALRPYRKAELLLRLQKDGLTQADKDALDGLLQQVANMSAKDGTCTLQDCMYKDVQKDWPG YSEGDQQLLKRVLVRKLCQPQSTGSLLGDPAASSPPGERGRSASPPQKRLQPPDFIDPLANKKPRISHFTQRAQPAVNGKLGVPNGREAL LPTPGPPASTDTLSSSTHLPPRLEPPRAHDPLADVSNDLGHSGRDCEHGEAAAPAPTVRLGLPLLTDCAQPSRPHGSPSRSKPKKKSKKH KDKERAAEDKPRAQLPDCAPATHATPGAPADTPGLNGTCSVSSVPTSTSETPDYLLKYAAISSSEQRQSYKNDFNAEYSEYRDLHARIER -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for CDC37-ELL |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CDC37-ELL |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for CDC37-ELL |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies